| abstract |
(57) [Summary]nThe present invention relates to the use of anticoagulants, especially PEG-hirudin, in preventing vascular complications after extracorporeal circulation when treating an individual for extracorporeal circulation. Thus, in particular, treating individuals with chronic renal failure who require regular hemodialysis, and the vascular complications that usually lead to high morbidity and mortality in dialysis patients who are treated for longer periods of time. It is possible to prevent. |